BluPax Pharma
BluPax Pharma is an independently owned, Edison, NJ-based wholesale distributor of prescription pharmaceuticals serving thousands of LTC, retail, specialty, chain, hospital, and government pharmacies across all 50 U.S. states with a 5,000+ SKU catalog sourced from 150+ manufacturers.
- Company typePrivate
- Founded2012
- HeadquartersEdison, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What BluPax Pharma does
BluPax Pharmaceuticals, LLC is an independently owned, New Jersey-based wholesale distributor of prescription pharmaceuticals founded in 2012 by Jacob Paskes, Joel Mittelman, and Avraham Yacobi. The company operates from a 40,000 square foot sales and distribution center in Edison, NJ, with offices and field representatives across six states, and is licensed to distribute in all 50 U.S. states, the District of Columbia, and Puerto Rico. BluPax serves thousands of pharmacies across long-term care, independent retail, national chains, specialty pharmacy, hospital, and government customer segments, offering a catalog of over 5,000 SKUs covering all dosage forms and therapeutic categories including Schedule CIII-V controlled substances.
The company purchases directly from 150+ manufacturers (including Pfizer, Moderna, Aurobindo, Prasco, and others) and resells to pharmacy customers through a multi-channel platform that includes a website ordering portal, a progressive mobile web app with barcode scanning, EDI integration, and direct relationships with pharmacy management systems such as PioneerRx, Liberty, SureCost, EzriRx, Pharmacy Marketplace, and UGORx. BluPax is NABP VAWD accredited, DEA licensed, and fully DSCSA compliant (with EPCIS-based data exchange implemented in August 2025), and reports a 99.5% fill rate with free next-day delivery nationwide. The technology stack includes a modern ERP system launched in April 2022, and the company maintains GPO relationships with FPN, Premier, MHA, Innovatix, and Gerimed to offer contracted pricing to member pharmacies.
BluPax generates revenue through a transactional wholesale model, taking margin on pharmaceutical product resales with no subscription requirements, no complex contracts, and no hidden fees. The go-to-market combines dedicated National Account Managers for enterprise and chain accounts with self-service digital ordering for SMB pharmacies, supplemented by fax ordering for legacy customers. The company also runs the PaxPoints loyalty rewards program (1 point per $100 spent on web orders) and a referral program that pays $25-$125 for referred pharmacy accounts. Notable milestones include shipping approximately 2% of all COVID-19 vaccines administered in the United States and being named a 2024 HDA Distribution Management Award finalist for vaccine distribution efforts.
BluPax Pharma firmographics
Firmographics- Name
- BluPax Pharma
- Legal name
- BluPax Pharmaceuticals, LLC
- Website
- https://blupaxpharma.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- BluPax Pharma is an independently owned, Edison, NJ-based wholesale distributor of prescription pharmaceuticals serving thousands of LTC, retail, specialty, chain, hospital, and government pharmacies across all 50 U.S. states with a 5,000+ SKU catalog sourced from 150+ manufacturers.
- Ownership category
- akta.pro rank
BluPax Pharma industry classification
Industry- Product category
- Pharmaceutical Wholesale Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA)
Keywords
Where BluPax Pharma is headquartered
LocationHeadquarters
- HQ city
- Edison
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
BluPax Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Infrastructure, Marketing or Sales
Revenue model
- Pharmaceutical Wholesale Distribution: BluPax operates as a wholesaler and distributor of prescription pharmaceuticals, generating revenue through the sale of pharmaceutical products to pharmacies and healthcare providers. The company purchases products from manufacturer partners and resells to customers with competitive pricing, no complex contracts or hidden fees. Revenue is transactional per order with no subscription requirements for customers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Pay-as-you-go | Standard wholesale pricing with transparent, competitive rates |
| Transaction based/ take rate | Monthly | PaxPoints Rewards Program |
Go-to-market motion3 records
Distribution channels6 records
Marketing channels8 records
BluPax Pharma product offering
Product offeringCore offering
BluPax Pharma is a B2B wholesaler and distributor of prescription pharmaceuticals, purchasing from 150+ direct manufacturer partners and reselling more than 5,000 SKUs across all dosage forms and therapeutic categories, including CIII-V controlled substances, to LTC, independent retail, specialty, and chain pharmacies, hospitals, and government accounts nationwide. The company supports ordering through its own website and progressive mobile web app, EDI, dedicated National Account Managers, and integrations with third-party pharmacy platforms, with DSCSA-compliant tracking and free next-day delivery on qualifying orders.
Product overview
BluPax Pharma is an independently owned prescription pharmaceutical wholesaler and distributor serving LTC, independent retail, specialty pharmacies, hospitals, and chains. The company operates primarily as a distribution business rather than a software platform, offering pharmaceutical products across a robust website ordering platform and mobile web app, with EDI and third-party marketplace integrations. Core offerings include the pharmaceutical distribution service (5,000+ SKUs in all dosage forms and therapeutic categories including CIII-V controlled substances), authorized vaccine distribution partnerships (Moderna Spikevax and Pfizer seasonal vaccines), the website ordering platform with features like shopping lists and credit card payments, and the mobile web app with barcode scanning. Add-on services include the PaxPoints customer rewards program and DSCSA compliance services. The company leverages over 150 direct manufacturer partners to achieve a 99.5% fill rate with free next-day delivery.
Differentiator
Problem solved
Functional benefit
Brands
- PaxPoints Rewards Program: Customer rewards program where customers earn PaxPoints on generic orders placed through the website. Points can be redeemed for savings on future orders.
Products and services
- Pharmaceutical Distribution Services B2B wholesale and distribution of prescription pharmaceuticals to LTC, independent retail, specialty, and chain pharmacies, hospitals, and government healthcare facilities. Catalog covers 5,000+ SKUs across all dosage forms and therapeutic categories, including CIII-V controlled substances, sourced from 150+ direct manufacturer partners with a 99.5% fill rate and free next-day delivery on qualifying orders.
- Moderna Spikevax Distribution Authorized distribution of Moderna's Spikevax COVID-19 vaccine through BluPax's Moderna P.E.R.K. Program partnership. Services direct contract pricing for members of GPOs such as FPN, MHA, Premier, Gerimed, and Innovatix.
- Pfizer Vaccines Distribution Authorized distribution of Pfizer's complete line of seasonal vaccines to BluPax customer pharmacies and healthcare providers. Supports direct contract pricing and GPO pricing agreements with quick onboarding, 24-48 hour order fulfillment, and no minimum order quantity requirements.
- PaxPoints Rewards Program Customer loyalty rewards program for direct web customers. Customers earn 1 PaxPoint per $100 spent on generic web orders, with each point valued at $1 and redeemable for savings at checkout on future orders. Points automatically added to account balance and expire at the end of the calendar month earned.
- DSCSA Compliance Services Drug Supply Chain Security Act compliance support for BluPax customer pharmacies, including EPCIS-based data exchange on every order, Authorized Trading Partner credentialing, and downloadable T3 pedigree documents made available in order details on the website.
Quantifiable outcome
- 99.5% fill rate achieved through 150+ manufacturer partnerships
- +3 more outcomes
Companies that use BluPax Pharma
Customer profileNamed customers6 records
Segments5 records
Ideal customer profiles4 records
BluPax Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration8 records
Feature4 records
BluPax Pharma partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered core and minor.
- LTC@HomecoreBluPax partnered with LTC@Home in September 2025 to provide members a consistent supply source with competitive pricing. LTC@Home is a national network supporting pharmacies delivering LTC services in home settings. The partnership expands BluPax's reach to more pharmacies servicing the growing long-term care at home segment.
- ModernacoreBluPax is a Moderna P.E.R.K. Program Partner (Preferred Efficient Retail Distribution) and can service direct contract pricing including members of FPN, Premier, MHA, Innovatix, and Gerimed GPOs. P.E.R.K. Program partners share commitment to exceptional service, streamlined onboarding, faster shipping, and distribution expertise.
- PfizercoreBluPax became an authorized distributor for Pfizer vaccines in July 2025, carrying Pfizer's complete line of seasonal vaccines. The company can service direct Pfizer contracts and GPO pricing agreements with 24-48 hour order fulfillment and no minimum order quantity requirements.
- Healthcare Distribution Alliance (HDA)coreHDA member company representing primary pharmaceutical distributors. BluPax participates in HDA initiatives, was highlighted for decade of growth, and was nominated for the Distribution Management Award for COVID-19 vaccine distribution efforts.
- FPN (Pharmacy Network)minorGroup Purchasing Organization whose members can access BluPax's services for Moderna and other pharmaceutical products through negotiated pricing agreements.
- Premier Inc.minorHealthcare improvement company and GPO whose members can access BluPax services for pharmaceutical distribution.
- MHA (Medical Healthcare Alliance)minorGPO whose members can access BluPax services for pharmaceutical distribution including Moderna products.
- Aurobindo PharmacoreFeatured manufacturer partner in June 2026. One of over 150 direct manufacturer partners supplying pharmaceutical products to BluPax catalog.
- Unichem LaboratoriescoreFeatured manufacturer partner in April 2026. Unichem Pharmaceuticals products available through BluPax catalog.
- AiPing Pharmaceutical Inc.coreFeatured manufacturer partner in July 2026. AiPing Pharma products available through BluPax catalog.
- Prasco LLCcoreBluPax began sourcing directly from Prasco Labs in June 2020, expanding their catalog with Prasco products.
- 100+ Manufacturer PartnerscoreBluPax maintains relationships with over 150 direct manufacturer partners including Accord Healthcare, Acella Pharmaceuticals, Aiping Pharma, Ajanta Pharma USA, Amneal Pharmaceuticals, Amring Pharmaceuticals, Aurobindo Pharma, and many others. These partnerships enable 99.5% fill rates and comprehensive product catalog.
- Pharmacy Podcast NetworkminorBluPax featured on Pharmacy Podcast Network with CMO Avi Maidenberg, providing marketing visibility to pharmacy industry audience.
- InnovatixminorGPO whose members can access BluPax services for pharmaceutical distribution including Moderna products.
- GerimedminorGPO focused on geriatric care whose members can access BluPax services for pharmaceutical distribution.
Scale indicators8 records
Recent moves6 records
Expansion highlights6 records
BluPax Pharma competitors and assessment
Company assessmentBroad incumbents
- Cardinal Health: Cardinal Health is the third member of the Big 3 US pharmaceutical wholesalers, providing drug distribution to retail pharmacies, hospitals, and health systems. It competes directly with BluPax for independent and chain pharmacy accounts, particularly through its wholesale distribution segment.
- Cencora (formerly AmerisourceBergen): Cencora is one of the Big 3 US pharmaceutical distributors, serving retail pharmacies, hospitals, and health systems. As one of the largest distribution incumbents, Cencora directly competes with BluPax for manufacturer contracts and pharmacy customers, particularly chains and large independents.
- McKesson Corporation: McKesson is the largest US pharmaceutical wholesaler, distributing brand and generic drugs to pharmacies, hospitals, and health systems nationwide. While BluPax competes at a smaller scale, both companies offer prescription pharmaceutical wholesale distribution to overlapping customer types (retail pharmacies, hospitals, chains) and compete for manufacturer distribution contracts.
Direct peers
- Morris & Dickson: Morris & Dickson is a mid-sized US pharmaceutical wholesale distributor serving independent retail pharmacies, LTC pharmacies, and hospitals — closely matching BluPax's core customer mix. Both companies compete on transparency, service quality, and technology-driven ordering for the independent pharmacy segment.
- Smith Drug Company (H.D. Smith): Smith Drug Company (formerly H.D. Smith) is a US pharmaceutical wholesaler focused on independent retail pharmacies, regional chains, and specialty distributors. It is a direct competitor to BluPax in the independent/community pharmacy wholesale segment.
- Rochester Drug Cooperative: Rochester Drug Cooperative is an independent, member-owned pharmaceutical wholesaler serving independent retail pharmacies. Like BluPax, it focuses on independent retail and LTC customers with competitive pricing and direct customer relationships as the value proposition against the Big 3.
Others
- SureCost: SureCost is a pharmacy procurement platform that enables independent pharmacies to compare distributor pricing and place orders. SureCost is one of BluPax's integrated third-party ordering platforms, classifying it as an adjacent ecosystem participant rather than a direct distributor.
- Pharmsaver: Pharmsaver is a third-party pharmaceutical marketplace platform that integrates with multiple distributors including BluPax. While not a direct distributor, it competes for the procurement workflow of independent pharmacies and is included as one of BluPax's third-party ordering integrations.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
BluPax Pharma social profiles
Digital presenceBluPax Pharma compliance and trust
Trust signalCompliance4 records
BluPax Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
BluPax Pharma leadership team
Management profileNumber of profiles
Profiles10 records
BluPax Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BluPax Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BluPax Pharma
What does BluPax Pharma do?
BluPax Pharma is a B2B wholesaler and distributor of prescription pharmaceuticals, purchasing from 150+ direct manufacturer partners and reselling more than 5,000 SKUs across all dosage forms and therapeutic categories, including CIII-V controlled substances, to LTC, independent retail, specialty, and chain pharmacies, hospitals, and government accounts nationwide. The company supports ordering through its own website and progressive mobile web app, EDI, dedicated National Account Managers, and integrations with third-party pharmacy platforms, with DSCSA-compliant tracking and free next-day delivery on qualifying orders.
Is BluPax Pharma a public or private company?
BluPax Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was BluPax Pharma founded?
BluPax Pharma was founded in 2012. It employs 11 to 50 people.
Where is BluPax Pharma based?
BluPax Pharma is headquartered in Edison, United States, in the North America region.
How does BluPax Pharma make money?
One revenue line is on record: pharmaceutical Wholesale Distribution.
Who are BluPax Pharma's main competitors?
Broad incumbents on record are Cardinal Health, Cencora (formerly AmerisourceBergen) and McKesson Corporation. Direct peers are Morris & Dickson, Smith Drug Company (H.D. Smith) and Rochester Drug Cooperative. Others are SureCost and Pharmsaver.
Does BluPax Pharma have an API?
No public API is recorded for BluPax Pharma.
What industry is BluPax Pharma in?
BluPax Pharma's product category is Pharmaceutical Wholesale Distribution. Its primary akta.pro industry code is CRAOAHAA, Prescription Pharmaceutical (Rx) Wholesale Distribution. Its NAICS code is 424210 and its SIC code is 5122.